HIF1A and breast cancer: A survey of the breast cancer cell lines MCF-7 and MDA-MB-231 revealed that hyperinsulinemia, not hyperglycemia, drives the activity of the HIF-1α rather than the one-way regulatory mechanism between HIF and glucose [45].